David Rolfe

David Rolfe

Last Update: 05-15-2015

Number of Stocks: 22
Number of New Stocks: 0

Total Value: $7,452 Mil
Q/Q Turnover: 5%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

David Rolfe Watch

  • David Rolfe Adds to Most Valuable Stakes in His Portfolio

    In his role as manager of Wedgewood Partners’ portfolio, David Rolfe (Trades, Portfolio)’s investment philosophy has been centered around the belief that significant wealth can be created by investing as “owners” of companies.

    Rolfe bought no new stocks in the first quarter, but he did add to several existing holdings, including the four most valuable stakes in his portfolio, reaffirming his “ownership” of each.  

  • 20 Questions With David Rolfe - Part II

    Read Part I of GuruFocus' interview with David Rolfe here.

    10. So basically you have a shortlist and the way you get this is, as I understand, is doing research on your clients’ requirements, even to get into the list?


  • 20 Questions With David Rolfe Part I

    Founder and CEO of GuruFocus, Charlie Tian, had the pleasure of interviewing David Rolfe (Trades, Portfolio) at this year’s Berkshire Hathaway (BRK.A)(BRK.B) shareholder meeting at Omaha. Rolfe discussed his current holdings, his most heavily weighted positions and even gave advice to young investors or those who are thinking about becoming investors but have not yet taken the leap.

    Rolfe is the CIO of Wedgewood Partners,, Inc. The top three sectors in his portfolio are technology (28.5%), financial services (17.2%) and healthcare (14.6%). His top three most heavily weighted stocks are: Qualcomm Inc (QCOM), Berkshire Hathaway Inc (BRK.B) and Express Scripts Holdings Co (ESRX).


  • David Rolfe Comments on Core Laboratories NV

    Core Laboratories (CLB) has carved out a dominant and exceptionally profitable niche in the oil service industry. The Company has a singular focus on obtaining, analyzing and rendering proprietary datasets related to the quality, efficiency and efficacy of a client’s oilfield production and development activities. In addition, the Company utilizes these data sets (and experience) to develop highly differentiated tools and equipment that are particularly useful during the development and production stages of an oilfield.

    In essence, Core Labs is “Big Data,” but considering that Core Labs was founded in the 1930’s, they were into “Big Data” well before the term started showing meaningful interest on Google Trends.


  • First Eagle is Long in National Oilwell

    In this article, let's take a look at National Oilwell Varco, Inc. (NOV), a $20.36 billion market cap company, which is a company that designs and manufactures drill rig equipment, provides down hole tools and services, and also provides supply chain integration services to the upstream oil and gas industry.

    Largest Shareholder


  • David Rolfe On When to Trim Berkshire Hathaway Position

    Why would you trim your stake in Berkshire Hathaway (BRK.A) (BRK.B)?

    Valuation, says David Rolfe (Trades, Portfolio) of Wedgewood Partners. Rolfe expects to own Berkshire for many years to come, but when the price to book value of Berkshire gets closer to 2, that position size should be reduced.


  • Rolfe Adds One Company to Portfolio in Fourth Quarter

    Guru David Rolfe (Trades, Portfolio), CFA and chief investment officer of Wedgewood Partners, has a small portfolio compared to many gurus, but he adheres to Westwood’s investment philosophy – significant long-term wealth can be created by investing as "owners" in companies.

    In the fourth quarter, Rolfe invested in only one company that is new to his portfolio – Core Laboratories NV (CLB) – but he made three separate purchases in it.


  • Wedgewood Partners Q4 2014 Client Letter - '2015 - Groundhog Day or Wizard of Oz?'

    Review and Outlook

    Our Composite (net-­‐of-­‐fees) gained +5.21% during the fourth quarter of 2014. This gain is in line with both the gains in the Standard & Poor’s 500 Index of +4.93% and the gain of +4.78% in the Russell 1000 Growth Index. The fourth quarter was the eighth quarter in a row of positive gains in the S&P 500 Index, and 9 out of the past 10. The last negative quarter in the stock market was back in the fourth quarter of 2012. That decline was just -­‐.38%. The S&P 500 Index did decline during the second quarter in 2012, but only a piddling decline of -­‐2.75%. The last meaningful quarterly decline in the stock market was registered in the third quarter of 2011 when the S&P 500 Index fell nearly -­‐14%. Said another way, the U.S. stock market has been straight up for 13 quarters – a streak nearly unmatched in the annals of stock market history. In addition, as if the tripling in the S&P 500 Index during the Great Bull Market was not enough for investors, the gain in average (or “median”) stock (Value Line Arithmetic Index) has been more than +75% greater than the capitalization-­‐weighted S&P 500 – or nearly five-­‐fold over the course of the Great Bull Market. (See chart of P/CF of median stock on top of page 10.) Lastly, as this Letter is being written, Mr. Market has awoken from his 2014-­‐volatility slumber. According to Investech, there were only 32 days in 2014 with daily moves of 1% -­‐ and only a single trading with a 2% move. As sober reminder, 2008 had 72 2% days and 2009 had 45.


  • Another Guru Goes for Oil - David Rolfe Buys Core Labs

    David Rolfe (Trades, Portfolio) is the latest guru to dip his toe in oil as more value-conscious investors eye the commodity’s 45% price slump from June peaks. Rolfe picked up shares of Core Laboratories NV (CLB), a global reservoir optimization technology company that enables its clients to extract more oil and gas from wells.

    Rolfe acquired 2,226,741 shares of the company reported Dec. 18 by GuruFocus Real Time Picks. His holding represents about 5% of the company. Core Laboratories shares traded around $121.68 per share on Friday, after a 36% decline year to date.


  • Hedge Fund Managers Greenblatt and Soros Are Betting On Mead Johnson Nutrition

    In this article, let's take a look at Mead Johnson Nutrition Company (MJN), a $18.56 billion market cap company that manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products.

    Attractive markets


  • David Rolfe's Wedgewood Partners Q3 2014 Portfolio Commentary

    Review and Outlook Our Composite (net-­of-­fees) was basically flat (+0.30%) during the third quarter of 2014. This rounding-­error gain is below both the gain in the Standard & Poor’s 500 Index of +1.13% and the gain of +1.49% in the Russell 1000 Growth Index.

    Our Composite year-­to-­date gain of +3.8% has lagged substantially the gains in the Standard & Poor’s 500 Index and the Russell 1000 Growth Index of +8.3% and +7.9%, respectively. A somber fact: Over the past six months, nearly two-thirds of our current portfolio has underperformed the S&P 500 Index. In the never ending zero-­interest rate environment of Quantitative Easing the chase for return and yield continues to reward the stocks of poorer quality (i.e. low/no profits), higher debt-­ leveraged company stocks and reward company stocks that pay out higher 2 percentages of earnings in the form of dividends. Individual stock selection mistakes aside, we believe that our investment focus on higher quality growth companies at reasonable valuations is simply ill-­suited in the current ebullient environment. In fact, 2014 may well go down as one of the worst years for active equity managers in the past two decades. According to The Leuthold Group: Last year provided managers not only with huge gains but also with comparatively favorable odds of beating the S&P 500. In 2013, about 60% of the issues in the 1500 composite topped the +29.6% gain in the S&P 500. That percentage has been cut in half over the last nine months. The latest reading of 30.2% compares to those recorded in the late 1990s’ “bifurcated bull” – an excruciating time for active managers that ultimately ended badly for all.


  • Stericycle: A Triple Screener Hit

    Just a generation ago, our collective attitude to hazardous waste might have been described as lackadaisical, at best. Syringes, bio-wastes and other waste products from the health care system often went into regular waste streams with little concern.

    Since then, however, that collective attitude has turned to vigilant, even hyper-vigilance sometime. We no longer accept anything but the utmost of care when managing and disposing of those wastes. It’s been sea change, and one that’s been driven by public awareness, legislation, and litigation.


  • Quickly Gain A Wealth Of Information From The GuruFocus Summary Page (Using Apple As An Example)

    When investing in a company, it is not only necessary to know about the company itself, but also how the stock is valued. Viewing a company through its summary page at GuruFocus provides a wealth of information to help understand its financial strength, profitability, growth and valuation, and see how the gurus and insiders are trading the stock. The features of the summary page can help you decide in minutes if not seconds whether or not to further investigate the stock for an investment opportunity. The summary page at GuruFocus should be your first destination when researching a particular stock.

    Using Apple (AAPL) as an example, towards the top of the page it can be seen that Apple is a very predictable company with its Business Predictability score of 4.5/5. By moving the mouse over the “question mark” next to the rating, a popup will appear giving more information about stocks with the same rating. Stocks with a 4.5/5 rating have gained 10.6 percent on average while back-testing for the past 10 years. Only 10 percent of the stocks lost money if held for 10 years.


  • Paul Tudor Jones, John Buckingham and Jim Simons Long in Coach

    In this article, let's take a look at Coach Inc. (COH), a $10.21 billion market cap company that designs, makes and markets fine accessories for women and men, including handbags, weekend and travel accessories, outerwear, footwear and business cases.

    Key drivers


  • Schlumberger is the Largest Oil-Service Company in the World and Fits Any Portfolio

    In this article, let's take a look at Schlumberger Limited (SLB), a $141.86 billion market cap company, which is a leading oilfield services company providing equipment and technology to the oil and gas industry worldwide.

    A dominant firm


  • Widely Held Guru Stocks Near Historical Low P/B Ratios

    Buying stocks at historically low price-to-book (P/B) ratios has been an effective strategy. The model portfolio, “Top 25 Historical Low P/B Ratio Companies”, has outperformed the S&P 500 by 29.51 percent since its inception in 2010. The following stocks are widely held by the investing gurus we follow and are trading near their historical low P/B ratios:

    Kellogg Company (K) is trading at a low P/B ratio of 6.10, near its 10-year low of 5.88. Its principle products are ready-to-eat cereals and convenience foods, such as cookies, crackers, savory snacks, toaster pastries, cereal bars, fruit-flavored snacks, frozen waffles and veggie foods. The 5- and 10-year median P/B ratios are 8.4 and 8.5. At the 5-year median, the stock would be priced at $87.60. Book value per share has been growing at an annual rate of 11.90 percent over the past five years. The stock is held by 18 gurus we follow with Hotchkis & Wiley having the largest holding of 2.43 million shares, representing 0.68 percent of the shares outstanding.


  • David Rolfe Comments on Apple

    Apple (AAPL), circa 2012-2014, is Exhibit A on how investing with the conviction of a successful business owner is a prerequisite for repeatable investment success. Before we explain, we would like to offer up pop quiz. Quick, off the top of your head, what is the 1-year, 2-year and 3-year return (roughly) of Apple stock (and the S&P 500 too) as of the end of the second quarter? Here is a graphic hint:


  • David Rolfe Comments on Coach

    Coach (COH) shares significantly declined during the quarter and have been a relative detractor since we first began purchasing shares in July 2012. With clearer hindsight, where did we go wrong on our initial timing? Our view then was that the Company's lackluster North American sales slump was largely due to a pause in creative new product. Thus, our initial investment in these shares came far too early in the Company's efforts to reinvigorate their iconic brand.

    Of course, the journey in our ownership in Coach, thus far, has been long...and wrong. When we initiated Coach, we recognized that there was increasing competitive encroachment in the North American handbag and accessories market. However, we underestimated the aggressive expansion of Coach’s competitors, as well as the pernicious effects of brand underinvestment during the previous business cycle. The core risk of Coach has been centered on its North American business, which has been losing share over the past, roughly 3 years. Competitors Michael Kors, Kate Spade and Tory Burch have all successfully copied key aspects of the high return on capital Coach playbook, and now the original progenitor of "accessible luxury" now finds itself at the crossroads of not only redefining and rebuilding its own brand, but fighting off it's well entrenched progeny. We still think Coach has a sustainable competitive advantage, and we do not think that the competitive inroads of Coach's peer group are sustainable over the next 3 to 5 years.


  • David Rolfe's Wedgewood Partners Q2 2014 Commentary

    Review and Outlook


  • David Rolfe Comments on Mead Johnson Nutrition

    Mead Johnson Nutrition (MJN)

    Edward Mead Johnson: founder of not one, but two great companies in his lifetime. Now, how many of us can say that?! In 1885, after graduating from the University of Michigan with a degree in law, he and his two brothers, Robert Wood Johnson I and James Wood Johnson, would found Johnson & Johnson, the consumer healthcare products company in Brunswick, New Jersey. With no lack of success, Edward soon 15 decided he wanted to do more. Ten short years later, he broke off from Johnson & Johnson and founded American Ferment Company in Jersey City, N.J., making nutritional products. Fast forward another ten years, in 1905 American Ferment re-­‐ established itself as Mead Johnson and Company and the +100 year history of the Mead Johnson Nutrition Company begins. While Mead Johnson's name has remained intact throughout its history, the company – with sales then of $131 million – was acquired in 1967 by Bristol-­‐Myers for $240 million. Bristol-­‐Myers Squibb owned Mead Johnson as a wholly owned subsidiary for the next four decades until they announced in April 2008 plans to sell 10-­‐20% of Mead Johnson to the public through an IPO in order to better focus on its burgeoning biopharmaceutical business. Bristol-­‐Myers Squibb would proceed to split off Mead Johnson and by February 2009 the IPO was complete. Shortly thereafter, in November of 2009, Bristol-­‐Myers would spin out the rest of their ownership of Mead Johnson in a stock swap, valued at $7.7 billion. Mead Johnson Nutrition would operate as a fully independent public company going forward.


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)